Security key
55234L204
Lyra Therapeutics, Inc. - Common Stock (LYRA)
CUSIP: 55234L204
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 493,700
- Total 13F value
- $4,423,417
- Share change
- +493,675
- SEC-reported price per share
- $8.96
- Number of holders
- 29
- Value change
- +$4,423,193
- Number of buys
- 28
- Shares outstanding
- 1,769,273
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
29
Top holders
10
LYRA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Lyra Therapeutics, Inc. SEC filings
Lyra Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55234L204
Recent filing periods:
Ownership snapshot
Top reported holders of LYRA - Lyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nantahala Capital Managem...
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 1.1%
13D/G row: Nantahala Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Nantahala Capital Management, LLC leads the comparable SEC ownership view at 1.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nantahala Capital Management, LLC's linked filing trail.
Comparable ownership
Top 5
Nantahala Capital Management, LLC
1.1%
PERCEPTIVE ADVISORS LLC
776%
BlackRock, Inc.
184%
VANGUARD GROUP INC
107%
Samsara BioCapital, LLC
85%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
|
1.1%
|
$84,253
702,106 shares
|
$0 | 30 Sep 2024 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
776%
|
$1,607,453
12,757,562 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
184%
|
$381,298
3,018,986 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
107%
|
$222,464
1,765,585 shares
|
— | 31 Mar 2025 |
| Samsara BioCapital, LLC |
13F
Company
|
85%
|
$175,573
1,390,130 shares
|
— | 31 Mar 2025 |
| Ikarian Capital, LLC |
13F
Company
|
64%
|
$133,645
1,058,148 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
493,700
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
22
Q2 2025 holders
29
Holder diff
7
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend